- Home
- / ASKA Pharmaceutical
ASKA Pharmaceutical
Revenue
¥52.5 B
FY, 2020
ASKA Pharmaceutical Summary
Company Summary
- Overview
- ASKA Pharmaceutical (あすか製薬株式会社) is a company that develops, manufactures, and sells pharmaceutical products. It offers drugs, therapies, and treatment systems in obstetrics and gynecology, urology, and rare diseases, as well as veterinary medicines.
- Type
- Subsidiary
- Status
- Active
- Founded
- 1920
- HQ
- Tokyo, JP | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Atsushi Maruo, Member of the Board of Directors, Vice Chairman of the Board
Sohta Yamaguchi, President, Member of the Board of Directors, Representative Director
Yutaka Kaihori, Member of the Board of Directors, Executive Corporate Officer
LocationsView all
23 locations detected
Tokyo, Tokyo HQ
Japan
1-5-1 Shibaura 2-chome, Minato-ku
Chiba, Chiba
Japan
REID-C Chiba Ekimae Bldg., 1-15-3, Benten, Chuo-ku
Fujisawa, Kanagawa
Japan
Fukuoka, Fukuoka
Japan
No.7 Myojo Bldg., 4-1-1, Tenjin, Chuo-ku
Hiroshima, Hiroshima
Japan
Hiroshima Nissei Midori Bldg., 8-18, Teppo-cho, Naka-ku
Iwaki, Fukushima
Japan
1, Otsurugi, Izumimachishimogawa
ASKA Pharmaceutical Financials
Summary Financials
- Revenue (Q3, 2021)
- ¥15.9B
- Gross profit (Q3, 2021)
- ¥8.2B
- Net income (Q3, 2021)
- ¥899.0M
- Cash (Q3, 2021)
- ¥10.8B
- EBIT (Q3, 2021)
- ¥1.2B